Skip to main content
Clinical Trials/JPRN-UMIN000020372
JPRN-UMIN000020372Completed未知

A study for evaluating the effects of oral intake of lactic acid bacteria on immune function after exercise. A randomized, double-blind, placebo- controlled trial. - A study for evaluating the effects of oral intake of lactic acid bacteria on immune function after exercise.

Juntendo University Graduate School of Medicine0 sites70 target enrollmentStarted: July 1, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)Individuals who can't stop drinking for 2 days before the days of screening and checkup. 2)Individuals who can't stop eating foods containing lactic acid bacteria and/or oligosaccharide, fermented foods during this study. 3)Individuals who can't stop eating functional foods which may affect immune functions. 4)Individuals who have a history of irritable bowel syndrome and Crohn's disease. 5) Individuals who have a medical history of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder. 6)Individuals who have chronic diseases and use medicines continuously. 7)Individuals who have under treatment or a history of drug addiction and/or alcoholism. 8)Individuals who are judged as unsuitable for this study based on the results of blood test. 9)Individuals with excessive alcohol-drinking behaviors. 10)Individuals who have a medical history of diseases affecting digestion and absorption. 11)Individuals who are pregnant, breastfeeding, or planning to be pregnant in the near future. 12)Individuals who are participating or willing to participate in other clinical trials. 13)Individuals whose family works for a company manufacturing or selling healthy foods or functional foods. 14)Individuals with steroid treatment. 15)Individuals who are seropositive against HBV antigen, HCV antibody, HIV antibody, or HTLV-1 antibody. 16)Individuals who are judged unsuitable for this study by the investigator for other reasons.

Investigators

Sponsor
Juntendo University Graduate School of Medicine

Similar Trials